0.49 USD
↗ 0.00 (0.04%)PRE MARKET (AS OF 05:49 AM EDT)
AIM ImmunoTech Inc.
AIMAMEX • USD
Market: OPEN
Open?$0.49
High?$0.49
Low?$0.49
Prev. Close?$0.49
Volume?1.3K
Avg. Volume?6.7M
VWAP?$0.49
Rel. Volume?0.00x
Bid / Ask
Bid?$0.49 × 100
Ask?$0.51 × 400
Spread?$0.02
Midpoint?$0.50
Valuation & Ratios
Market Cap?4.0M
Shares Out?8.1M
Float?3.1M
Float %?95.3%
P/E Ratio?N/A
P/B Ratio?-0.41
EPS?-$1.71
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.53Weak
Quick Ratio?0.53Weak
Cash Ratio?0.48Low
Debt/Equity?-0.46Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?-0.41CHEAP▾
P/S?45.37HIGH▾
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
EV/Sales?62.31HIGH▾
Returns & Efficiency
ROE?142.7%STRONG▾
ROA?-241.4%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$5.5M
News
Profile
AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies. Its flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) molecule being developed for globally important cancers, viral diseases, and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe Chronic Fatigue Syndrome (CFS).
Employees
21
Market Cap
4.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1995-11-02
Address
2117 SW HIGHWAY 484
OCALA, FL 32801
Phone: 352-448-7797
OCALA, FL 32801
Phone: 352-448-7797